Refine by
Heart Failure Articles & Analysis
56 articles found
Any disruption in this system can lead to conditions such as hypertension, atherosclerosis, and heart failure. Research in cardiovascular biology aims to unravel the underlying causes of these diseases and improve therapeutic interventions. ...
In today’s fast-paced healthcare environment, innovation and cost-efficiency are key. For healthcare providers looking to enhance patient care while managing expenses, renting mobile ECG (electrocardiogram) devices offers a compelling solution. This approach not only improves patient access to vital heart monitoring but also provides significant benefits for healthcare practices. ...
ByPanonIT
Do you have fragmented sleep all through the night? Do you wake up oftentimes at night, struggling to breathe? Is your partner tired of your heavy snoring and often reminds you to see a doctor? Well, if your chronic, frequent snoring is associated with sleep apnea, there are a number of factors and issues to be aware of. Basically, it’s a matter of cause and effect with sleep apnea ...
Understanding Sleep Apnea and Its Types Sleep apnea is a sleep-related breathing disorder that results in poor sleep quality and can lead to daytime fatigue or sleepiness, forgetfulness, and irritability. According to the Mayo Clinic, there are 3 types of sleep apnea to be aware of as follows: OSA or obstructive sleep apnea is the more common form of the disorder and affects roughly 30% of ...
In honor of World Heart Day on September 29, we're diving into the world of cardiovascular diagnostics. ...
Sepsis is a severe bodily reaction to infection, which can cause fever, breathlessness, disorientation, tissue damage, and organ failure, among other symptoms. While bacterial infections are the primary culprits, any other infection such as from pneumonia or influenza may lead to sepsis if not appropriately treated. ...
FGL2 and disease Studies have found that FGL2 is highly expressed in microvascular endothelial cells, causing microcirculatory disturbance, promoting myocardial and liver ischemia-reperfusion injury, arthritis, type 2 diabetic heart failure, and type 2 diabetic nephropathy; FGL2 is highly expressed in inflammatory bowel disease mucosa , correlated with disease ...
In speaking about EchoGo® Heart Failure with Cardiovascular Business, Dr. Pellikka says, "I think the potential there is ...
*Synthetic Vericiguat Acting as a stimulator of soluble guanylate cyclase (sGC), Vericiguat catalyzes the synthesis of intracellular cyclic guanosine monophosphate (cGMP) and increases intracellular cGMP levels, thereby relaxing smooth muscle and vasodilating for heart failure. The drug, developed by Bayer AG and approved by the FDA in 2021, is the first to be ...
Preliminary results of a large-scale study demonstrating the clinical benefits of EchoGo® Heart Failure were shared at the American College of Cardiology (ACC 2023) conference last month. ...
Compared with metformin, SGLT-2 inhibitors as first-line treatment can significantly reduce the risk of hospitalization for heart failure by 22%. 2. For patients with previous cardiovascular disease, the risk of myocardial infarction was also significantly reduced. 3. ...
Abnormalities in muscle function are observed in many inherited or acquired diseases, such as muscular dystrophy, chronic obstructive pulmonary disease, and congestive heart failure. The Palpator is a high-throughput mechanical tissue analyzer that measures the mechanical properties of engineered tissues growing in 96- or 384-well plates and allows chemical ...
Heart failure affects about 6.2 million Americans and is rising in prevalence. ...
Heart failure with preserved ejection fraction (HFpEF) is a multifactorial and multisystemic disorder that represents more than 50% of all heart failure cases.[1] Epidemiologic data from the Framingham Study, an international cohort study, shows a rapid increase in the prevalence of HFpEF over the past three decades, from 41% to ...
Heart failure with preserved ejection fraction (HFpEF) is currently affecting over half of heart failure patients. ...
Heart failure with preserved ejection fraction (HFpEF) has recently been recognized as the single greatest unmet need in cardiovascular medicine, overtaking heart failure with reduced ejection fraction (HFrEF) and becoming the most common form of heart failure, with a prevalence that is ...
Diastolic heart failure has many of the same symptoms as other types of heart failure. ...
Recent clinical trials investigating sodium-glucose cotransporter 2 inhibitors (SGLT2i) have highlighted that this drug is highly effective in treating patients with heart failure with preserved ejection fraction (HFpEF). HFpEF is a complex disease which accounts for more than half of all heart failure (HF) hospital admissions ...
Barostim™ Brief Summary for Physicians The Barostim System is indicated for the improvement of symptoms of heart failure—quality of life, six-minute hall walk and functional status—for patients who remain symptomatic despite treatment with guideline-directed medical therapy, are NYHA Class III or Class II (who had a recent history of Class ...
ByCVRx
In this review, we provide an overview of the pathophysiology of acute decompensated heart failure, current management strategies, and failed pharmacological therapies. ...